Horlicks Women’s Plus Insight into Women's Nutritional Needs

Industry and Competitive Context

India's Health Food Drinks (HFD) category, comprising malted and powdered nutritional beverages typically consumed mixed with milk or water, has historically been one of the most consolidated segments in the Indian FMCG market. For decades, Horlicks occupied a dominant leadership position in this category, holding a 52.6 percent volume market share as per Nielsen data cited in industry reporting from the 2008-09 measurement period. Competitors including Bournvita, Boost, and Complan each held shares in the range of 12 to 17 percent, collectively positioning Horlicks as a near-monopoly in consumer trust and household penetration. The category's retail size, estimated by Marketing Weekly at approximately Rs 5,500 crore during Horlicks's GSK-era peak and growing to an estimated Rs 13,000 to 15,000 crore by 2024 according to publicly available industry assessments, reflects both demographic tailwinds and the rising salience of nutrition as a consumer concern.

The structural character of this category underwent a fundamental realignment when Hindustan Unilever Limited (HUL) announced its merger with GlaxoSmithKline Consumer Healthcare India in December 2018. The transaction, completed on April 1, 2020, brought the Horlicks, Boost, Maltova, and Viva brands under HUL's portfolio. As confirmed in official statements from both HUL and GSK, HUL separately acquired the Horlicks brand rights for the Indian market for EUR 375.6 million, equivalent to approximately Rs 3,045 crore, eliminating future royalty obligations and embedding the brand permanently within HUL's consumer goods architecture. The combined Horlicks and Boost portfolio was reported at the time to command nearly 60 percent of the HFD category, conferring immediate category leadership on HUL as it sought to anchor a health and wellness growth platform within its Foods and Refreshment division.

Despite category leadership at the master brand level, the competitive landscape for women-targeted nutritional products remained notably underdeveloped at the time Women's Horlicks was originally conceptualized. No comparable nationally marketed nutritional drink existed specifically for adult Indian women, creating a category gap that GSK Consumer Healthcare was the first to identify and commercially pursue.

Brand Situation Prior to Campaign

Women's Horlicks was launched by GSK Consumer Healthcare in 2008 as the first milk additive developed specifically for adult women in the Indian market. The brand's early years established the basic proposition that women, unlike children who were the primary HFD target, had distinct and underserved nutritional requirements. By 2013, according to reporting in the Economic Times, the brand crossed Rs 100 crore in annual sales, a commercially meaningful milestone particularly given the brand's reliance on in-store activation and on-ground engagement rather than heavy above-the-line advertising expenditure. The same Economic Times reporting observed that Women's Horlicks was growing at a pace faster than Sensodyne toothpaste and the parent Horlicks franchise despite premium pricing and a general slowdown in discretionary consumer spending, with the company attributing the trajectory to a shift in consumer demographics, specifically the observation that women were increasingly focused on personal health and not only on family nutrition.

Despite this early commercial traction, the brand faced a strategic ceiling by the mid-2010s. As market leader in a niche it had itself created, it operated without meaningful competitive pressure but also without a clearly defined and culturally resonant reason-to-believe that could meaningfully expand its consumer base beyond early adopters. The prevailing product communication was anchored around bone mineral density and calcium adequacy but had not yet translated these clinical claims into an emotionally compelling narrative capable of driving mass market penetration. The brand's positioning remained functional rather than aspirational, addressing a physiological need without connecting to the evolving social identity and self-perception of its target consumer.

Following HUL's 2020 acquisition, the product was formally renamed from "Women's Horlicks" to "Horlicks Women's Plus," a change reflected consistently across HUL's brand website and retail listings including Apollo Pharmacy and major e-commerce platforms, which explicitly documented the new name as the successor to the earlier brand. The renaming was accompanied by a product reformulation built around a proprietary nutrient combination described by HUL as its "CALSEAL" formula, comprising Calcium, Vitamin D, and Vitamin K2. HUL's official brand communications state that two servings of 60 grams deliver 100 percent of the Indian Council of Medical Research (ICMR) 2010 recommended daily allowance of these three nutrients for women. The brand further states that the formulation is clinically proven to help improve bone strength within six months, referencing a study published in the peer-reviewed journal Nutrients in 2021.

Strategic Objective

The strategic objectives of Horlicks Women's Plus, as reconstructed from official press releases, corporate statements, and publicly documented campaign briefs, operated across two interconnected but distinct levels. The first and more immediate objective was to shift the brand's cultural register from a narrowly functional health product to a symbol of women's physical agency and autonomy, thereby broadening the brand's emotional relevance beyond its existing nutritionally aware consumer base. The second objective was category expansion, specifically converting the large and largely unaware population of women experiencing bone-related symptoms from passive acceptors of symptomatic remedies such as pain-relief ointments into proactive seekers of nutritional solutions. Both objectives were informed by a diagnosis, confirmed through primary research conducted by the brand, that the scale of the nutritional problem among Indian women far exceeded the scale of consumer awareness of that problem.

An additional commercial imperative emerged following HUL's acquisition: to validate the substantial premium paid for the Horlicks brand franchise by demonstrating that extensions like Women's Plus could drive category expansion and premiumization, rather than cannibalizing the parent brand's mass-market positioning.

Campaign Architecture and Execution

The foundational campaign platform for the brand was launched in December 2017 under GSK Consumer Healthcare, in partnership with creative agency FCB India, under the title "Stand Strong" and the corresponding hashtag hashtag StandStrong. The campaign signed actor Taapsee Pannu as its brand ambassador, a deliberate choice of a public figure known for taking roles that challenge conventional representations of femininity in mainstream Indian cinema. The initial creative execution featured Pannu navigating the physical demands of a full day, with the narrative centered on how bone strength functioned as a structural foundation for women's ability to pursue their ambitions without interruption. Vikram Bahl, then Area Marketing Lead for Nutrition and Digestive Health at GSK Consumer Healthcare India, described the platform publicly as targeted at women over thirty and intended to build a conversation around proactive bone health rather than reactive symptom management.

The platform was extended in March 2019 through a second creative phase that pivoted from a celebrity-centered execution to a real-women narrative model. This phase featured Dr. Seema Rao, described in media coverage as India's first woman commando trainer; Ratna Singh, identified as India's first female wildlife naturalist; and Uma Das, described as India's first woman Dhaki player. These women were presented as individuals whose professional choices had been enabled by physical strength, with their stories intended to reframe strength not as a male attribute but as a precondition for women's unconventional ambition. The campaign simultaneously invited consumers to submit their own stories under the StandStrong hashtag, extending the brand narrative beyond paid media into earned and participatory content. FCB India's Chief Creative Officer Swati Bhattacharya was credited with the campaign's creative direction. The Unstereotype Alliance, a United Nations Women-backed initiative co-founded by Unilever among others, formally documented the campaign as a case study in progressive gender representation, noting its goal of breaking the stereotypical image of Indian women in advertising as dutiful daughters, wives, and mothers.

Following HUL's ownership transition, the campaign infrastructure was further institutionalized through a structured partnership with the healthcare infrastructure sector. In January 2022, Horlicks Women's Plus launched a joint awareness initiative with Apollo Clinics, offering free Vitamin D testing to women above thirty years of age across Apollo clinic centers. Krishnan Sundaram, Vice President for Nutrition at HUL, described the partnership in official press releases as aligned with the company's stated purpose of driving a culture of wellbeing in India. The initiative was reported by Mediabrief to have resulted in more than 18,000 women tested within its initial phase. By December 2024, a press release confirmed that Horlicks Women's Plus and Apollo Diagnostics were entering their fourth consecutive year of partnership, with Vitamin D tests made available at more than 2,000 Apollo Diagnostic centres across over 200 cities at a subsidized price of Rs 199, against a standard market price of Rs 1,850. The 2024 campaign, as communicated by Shiva Krishnamurthy, Executive Director of Foods and Refreshment at HUL, was designed to reach more than 50 million women, with Taapsee Pannu continuing in her ambassador role.

Positioning and Consumer Insight

The brand's core consumer insight was surfaced and formalized through a large-scale primary research exercise conducted in 2023 by Horlicks Women's Plus in collaboration with content platform Momspresso. The survey covered more than 1,500 women across Maharashtra, Delhi, Tamil Nadu, West Bengal, Andhra Pradesh, and Karnataka, representing a cross-regional sample across major urban geographies. The findings revealed a significant and strategically actionable gap between the incidence of the problem and consumer awareness of its cause. Nine out of ten women reported experiencing some form of body ache, including backache, neck ache, or joint pain, within any given year, with 71 percent specifically reporting backaches. Approximately 44 percent reported experiencing such pains as frequently as three to four times per month. Despite this near-universal symptom prevalence, more than 60 percent of respondents were unable to identify the primary cause of their aches, and 87 percent were entirely unaware that poor bone health could be a contributing factor. Compounding this awareness deficit, 72 percent of respondents reported managing their discomfort through temporary symptomatic relief measures such as ointments and balms, rather than addressing underlying nutritional causes. Krishnan Sundaram's official statement accompanying the 2023 campaign explicitly framed the insight as follows: as women age, typically after the age of thirty, there is a decline in bone density that may result in frequent aches and pains during activities as routine as standing for extended periods, bending at the knees, or lifting objects.

This research gave the brand a double positioning mandate. First, it needed to function as a category educator, creating awareness of the link between routine pain and bone health before it could credibly offer a product solution. Second, it needed to reframe the purchase decision from a reactive, symptomatic response to a proactive, preventive investment in long-term physical capability. The positioning thus operated against two simultaneous competitors: the general ignorance of bone health as a category, and the entrenched behavior of relying on balms and ointments as the default management strategy for the symptom. Both represented substitutes for nutritional intervention rather than direct competitive brands within the HFD segment.

Media and Channel Strategy

Based on publicly documented sources, the brand's communication architecture integrated television advertising, digital and social media, earned media through real-women narratives, and experiential healthcare activation. The Stand Strong campaign deployed a television commercial as its primary reach vehicle, with Taapsee Pannu's daily routine serving as the central creative device. The 2019 extension into real-women stories was amplified through digital platforms and an invitation for user-generated content submissions, reflecting a shift toward community-driven engagement aligned with evolving media consumption patterns among the brand's target demographic of urban women between thirty and fifty years of age.

The Apollo partnership represents the most structurally significant channel innovation in the brand's post-acquisition period. By embedding the brand within a diagnostics and healthcare infrastructure across more than 2,000 centers in more than 200 cities, HUL transformed Horlicks Women's Plus from a product promoted through conventional advertising channels into one integrated into the preventive healthcare consideration set. This is a channel strategy that few FMCG brands at comparable price points have adopted at scale in India. The affordability of the subsidized test, priced at Rs 199 versus the Rs 1,850 market rate, removed economic barriers to trial of the diagnostic service and created a moment of truth, the Vitamin D test result itself, that functioned as a naturalistic reason to consider the product without requiring the brand to make the claim directly. No verified public data is available on the split of media investment across channels, precise reach metrics by platform, or the total advertising expenditure allocated to the Horlicks Women's Plus franchise in any specific financial year.

Business and Brand Outcomes

The documented brand outcomes associated with the Horlicks Women's Plus strategy span multiple dimensions, though granular financial performance data specific to this sub-brand has not been publicly disclosed by HUL. On the brand-building dimension, the StandStrong campaign was recognized by the Unstereotype Alliance as a demonstrated case of progressive women's representation in Indian advertising, conferring reputational validation from a globally credible institutional source. The 2022 Apollo partnership was publicly credited with generating more than 18,000 diagnostic tests within its initial campaign window. The 2024 iteration targeted a reach of more than 50 million women through multiple communication touchpoints, as stated in official press releases.

No verified public information is available on Horlicks Women's Plus's standalone market share within the women's nutritional beverage segment, annual revenue figures post-HUL acquisition, household penetration rates, or consumer sentiment scores at any specific measured point. HUL's public disclosures aggregate the Horlicks portfolio and do not break out performance at the sub-brand level in a manner that permits independent verification of Women's Plus-specific business outcomes.

At the category level, the brand's sustained presence across a decade and a half, its continuity of investment through three distinct creative phases, its ambassador retention, and its multi-year institutional partnerships with Apollo constitute indirect evidence of commercial viability, as underperforming extensions in HUL's portfolio have historically been rationalized or discontinued. The company's public framing of Horlicks Women's Plus as "market leader in women's wellbeing" within official corporate statements further suggests category leadership by their own internal measurement, though the methodology of this claim has not been independently audited in a publicly accessible source.

Strategic Implications

The Horlicks Women's Plus case offers a substantive illustration of how a brand can build category primacy in a segment it defines entirely by itself. The first and most durable strategic insight is the power of the category creation framework over competitive positioning. By identifying and naming a problem, which is the intersection of women's bone health ignorance and symptom normalization, rather than positioning against an existing competitor, the brand was able to construct a reference frame in which it was the only credible solution. This approach required a long horizon and significant upstream investment in awareness building before demand could be harvested at scale.

The second implication concerns the strategic use of healthcare infrastructure as a distribution and trust-building mechanism. The Apollo partnership is not merely a promotional initiative but a structural embedding of the brand within the diagnostic consideration journey. When a woman receives a Vitamin D deficiency result, the brand that educated her about Vitamin D deficiency is already in her awareness frame. This is a sophisticated form of need-state marketing that operates before the purchase funnel has conventionally begun. It also raises the brand's credibility by association with a clinical infrastructure rather than relying solely on advertising claims.

The third implication involves the role of purpose-driven advertising as a category expander. The StandStrong platform, by anchoring bone health within the language of women's ambition, physical freedom, and unconventional aspiration, transformed a clinical and somewhat abstract product benefit into a culturally relevant narrative. The choice of Taapsee Pannu, an actress who was then building a commercial identity around breaking conventional gender expectations in her film work, was strategically coherent rather than merely aspirational. The extension into real women rather than celebrities in 2019 deepened this authenticity claim without abandoning the brand's core positioning.

The fourth implication is structural. The HUL acquisition and the accompanying brand renaming and reformulation provide a case study in how portfolio transitions can be managed without discontinuity of consumer trust, provided the underlying brand promise is preserved and the platform investment is sustained. The continuity of the ambassador, the campaign hashtag, and the bone-health narrative across the ownership transition suggests a deliberate stewardship decision to protect the brand's earned positioning rather than impose a new direction aligned with HUL's corporate aesthetic preferences.

Finally, the Momspresso survey of 2023 illustrates the strategic value of proprietary consumer research as a campaign-justification instrument. By commissioning and publishing large-scale primary data that quantifies both the scale of a health problem and the depth of consumer ignorance about its cause, the brand was able to simultaneously generate earned media coverage, provide a journalistically credible rationale for its campaign, and underline the social legitimacy of its commercial objective. This use of research as a communication asset, not merely an internal planning tool, is a technique with wide strategic applicability in health and wellness marketing.

Discussion Questions

1. Horlicks Women's Plus pursued a category creation strategy rather than a competitive positioning strategy. What are the specific conditions under which category creation offers a superior strategic payoff compared to differentiated positioning within an existing category, and how long does a brand typically need to sustain investment before the created category generates defensible returns?

2. The brand's partnership with Apollo Diagnostics embeds it within a healthcare diagnostic pathway prior to any product consideration by the consumer. Evaluate the risks and rewards of this approach relative to conventional FMCG channel strategies, including the long-term dependency this creates on a single institutional partner.

3. The StandStrong platform transitioned from a celebrity-led execution in 2017 to a real-women narrative in 2019. From a brand positioning standpoint, assess the strategic trade-offs between these two creative models in terms of reach, authenticity, scalability, and long-term brand equity.

4. The 2023 Momspresso survey found that 87 percent of surveyed women were unaware that poor bone health could cause their body aches. How should a brand ethically navigate the use of consumer ignorance as a marketing lever, and what guardrails should govern the commercial exploitation of documented knowledge gaps in the health and wellness category?

5. Following HUL's acquisition of the Horlicks brand for Rs 3,045 crore in brand rights alone, what strategic criteria should HUL apply to determine whether Horlicks Women's Plus justifies continued standalone investment as a distinct sub-brand, or whether its equity should be folded into a broader Horlicks health platform targeting multiple life stages?